GOOD NEWS! Researchers have discovered a new antibiotic, known as manikomycin, that may be a bulwark in the fight against drug-resistant superbugs. By attacking the ribosome in a never-before-seen way, manikomycin can evade the existing mechanisms pathogens have developed to resist antibiotics.
